Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Feb 15, 2017, 08:00 ET Everon Biosciences Publishes a Study Suggesting a New Biomarker of Senescent Cells for Anti-Aging Research and Drug Development

Today, a research team from Everon Biosciences, Inc. and Roswell Park Cancer Institute has published a new study in Proceedings of the National...


Feb 15, 2017, 08:00 ET Bayer to Showcase Oncology Data at ASCO GU 2017

Bayer announced today that its latest research findings on Xofigo® (radium Ra 223 dichloride) injection will be presented at the 2017 Genitourinary...


Feb 15, 2017, 07:00 ET Bpifrance awards PathMaker Neurosystems a PIA Grant to Support Product Development

PathMaker Neurosystems Inc. ("PathMaker"), a clinical-stage neuromodulation company developing non-invasive systems for the treatment of patients...


Feb 15, 2017, 06:30 ET Ardelyx Announces Successful Phase 3 Trial of Tenapanor for Hyperphosphatemia in Patients with End-Stage Renal Disease

Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage company focused on enhancing the treatment of patients with cardiorenal and gastrointestinal (GI)...


Feb 15, 2017, 06:00 ET L'FDA ha Approvato per il Mercato Americano Tirosint-SOL, Levotiroxina, Formulazione Liquida, Brevetto IBSA

Studi Clinici hanno Dimostrato che Tirosint-SOL è in Grado di Superare Alcuni Limiti Delle Compresse di Levotiroxina IBSA annuncia oggi che US...


Feb 15, 2017, 04:21 ET Biosensors annonce le recrutement du premier patient dans le nouvel essai pivot américain de BioFreedom, « LEADERS FREE II »

Biosensors International Group, Ltd. (« Biosensors » ou la « Société »), un développeur, fabricant et distributeur de dispositifs médicaux...


Feb 15, 2017, 02:00 ET La FDA ha aprobado Tirosint-SOL, levotiroxina en solución líquida para el mercado americano, patente IBSA

Estudios clínicos han demostrado que Tirosint-sol podría superar algunas de las limitaciones de las tabletas de levotiroxina IBSA anunció...


Feb 15, 2017, 02:00 ET La FDA a approuvé Tirosint-SOL (lévothyroxine en solution liquide) pour le marché américain, avec un brevet IBSA

Des études cliniques ont démontré que Tirosint-SOL peut vaincre certaines des limites inhérentes aux comprimés de lévothyroxine IBSA a...


Feb 15, 2017, 02:00 ET Strekin AG présente les plus récentes avancées de la phase 2 du développement du STR001, ainsi que de nouvelles données précliniques sur la perte auditive

Strekin AG, entreprise bio-pharmaceutique privée en phase cliniques, a annoncé aujourd'hui la présentation de nouvelles données à l'occasion de la...


Feb 15, 2017, 02:00 ET Strekin AG presenta la actualización del desarrollo en fase 2 de STR001

- Strekin AG presenta la actualización del desarrollo en fase 2 de STR001 y los nuevos datos preclínicos para pérdida auditiva...


Feb 15, 2017, 02:00 ET FDA genehmigt Tirosint-SOL, Levothyroxin in flüssiger Lösung, für den amerikanischen Markt - Patent von IBSA

Klinische Studien haben gezeigt, dass Tirosint-SOL einige der Einschränkungen von Levothyroxin-Tabletten überwinden IBSA hat heute...


Feb 15, 2017, 02:00 ET Strekin AG präsentiert aktuellen Stand der Phase-2-Entwicklung von STR001 und neue präklinische Daten zum Hörverlust

Strekin AG, ein auf klinischer Stufe aktives Biopharma-Unternehmen im Privatbesitz, gab heute bei der Konferenz der Association for Research in...


Feb 14, 2017, 19:00 ET Theratechnologies Announces New Data from the Pivotal Phase III Trial of HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab

Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced today that additional secondary efficacy and safety endpoint results from the...


Feb 14, 2017, 13:00 ET PharmaForce International: U.S. HEOR Personnel Deployed In a Field Capacity Increased by More Than 50%

The report published by PharmaForce International shows a 53% increase in field-based HEOR personnel when examining a cross-section of 10 leading...


Feb 14, 2017, 10:00 ET Double-blind, randomized crossover study of intravenous infusion of magnesium sulfate

According to Life Extension, a Fort Lauderdale, Fla.-based pioneer reporting the latest anti-aging research and integrative health therapies, in...


Feb 14, 2017, 09:00 ET Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab) In Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Amgen (NASDAQ:AMGN) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration...


Feb 14, 2017, 08:40 ET ProTrials Research, Inc. Expands Clinical Research Capabilities to Include Data Management Services

ProTrials Research, Inc., a leader in the clinical research organization (CRO) industry, announced today the expansion of their suite of services...


Feb 14, 2017, 08:30 ET Armetheon Announces European Medicines Agency's Support for 1000 Patient Single Phase 3 Study prior to MAA Filing for its Novel Oral Anticoagulant Tecarfarin

Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced it has...


Feb 14, 2017, 08:00 ET GenomeDx's Decipher Prostate, GRID and Bladder Data to be Featured in Multiple Presentations at the 2017 Genitourinary Cancers Symposium

GenomeDx Biosciences today announced that oral and poster presentations featuring Decipher® Prostate Cancer Classifier tests, Genomics Resource...


Feb 14, 2017, 08:00 ET Prostate Cancer Foundation Announces New Recipients of 2016 PCF Challenge Awards to Promote Research in Deadly Prostate Cancer

The Prostate Cancer Foundation (PCF) today announced that it has granted eight new 2016 PCF Challenge Awards to advance treatments and cures for...


Feb 14, 2017, 07:05 ET Viking Therapeutics and PoC Capital Enter Agreement to Fund Clinical Development of VK2809 in Glycogen Storage Disease Ia (GSD Ia)

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...


Feb 14, 2017, 07:00 ET Ionis Earns $75 Million from Bayer for Advancing IONIS-FXI Rx and IONIS-FXI-L Rx

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today the advancement of IONIS-FXIRx in clinical development under an existing exclusive...


Feb 14, 2017, 06:00 ET ContraVir to Highlight Clinical Data from Ongoing Phase 2a Study of Tenofovir Exalidex (TXL™) for Treating Hepatitis B

ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted...


Feb 14, 2017, 03:00 ET Le vaccin PfSPZ-Cvac de Sanaria offre un haut niveau de protection contre le paludisme lors d'une étude clinique

SOUS EMBARGO JUSQU'AU 15 février à 13h00, heure française Dans un rapport publié aujourd'hui par le magazine Nature, (Sterile protection...


Feb 14, 2017, 03:00 ET PfSPZ-CVac-Malariaimpfstoff von Sanaria erzielt in klinischer Studie hohen Schutzgrad

GESPERRT BIS 15. FEB., 13:00 UHR OSTKÜSTENZEIT In einem heute in Nature veröffentlichten Artikel (Sterile protection against human malaria by...